Stay updated on Anti-viral Therapy in Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page.

Latest updates to the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No study details or content were changed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2. The visible study details and sections appear unchanged.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedAdded the VALAD JAMA publication citation (Devanand et al., 2026) and deleted the 2025 ahead-of-print citation.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to core content, study data, or site navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1 with no observed changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedNew VALAD trial publication citation added: Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial (JAMA). Results-status updates are now displayed (Results First Posted; Last Update Submitted that Met QC Criteria; Last Update Posted) along with revision notes (No FEAR Act Data; Revision: v3.4.0).SummaryDifference0.4%

Stay in the know with updates to Anti-viral Therapy in Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page.